Matthew J. Ehrhardt, MD, MS
Matthew J. Ehrhardt, MD, MS

Matthew J. Ehrhardt, MD, MS

Assistant Member, St. Jude Faculty

Departments

Divisions

Education

  • BS – University of Illinois, Urbana-Champaign
  • MD – University of Illinois College of Medicine at Peoria
  • MS – Medical College of Wisconsin, Milwaukee

Research Interests

  • Late effects of childhood cancer therapy
  • Hodgkin and non-Hodgkin lymphomas

Selected Publications

Hudson MM, Ehrhardt MJ, Bhakta N, Baassiri M, Eissa H, Chemaitilly W, Green DM, Mulrooney DA, Armstrong GT, Brinkman TM, Klosky JL, Krull KR, Sabin ND, Wilson CL, Huang IC, Bass JK, Hale K, Kaste S, Khan RB, Srivastava DK, Yasui Y, Joshi VM, Srinivasan S, Stokes D, Hoehn ME, Wilson M, Ness KK, Robison LL. Approach for classification and severity-grading of long-term and late-onset health events among childhood cancer survivors in the St. Jude Lifetime Cohort. Canc Epidemiol Biomarkers Prev 2016. Epub ahead of print. Pubmed PMID: 28035022.

Ehrhardt MJ, Sandlund JT, Zhang N, Liu W, Bhakta N, Ness KK, Chemaitilly W, Krull KR, Brinkman TM, Crom DB, Kun L, Kaste SC, Armstrong GT, Green DM, Srivastava K, Robison LL, Hudson MM, Mulrooney DA. Late outcomes among adult survivors of childhood non-Hodgkin lymphoma (NHL): a report from the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer 2016. Epub ahead of print. Pubmed PMID: 27860222.

Ehrhardt MJ, Bhakta N, Liu Q, Yasui Y, Krasin MJ, Mulrooney DA, Hudson MM, Robison LL. Absence of basal cell carcinoma in irradiated childhood cancer survivors of black race: a report from the St. Jude Lifetime Cohort Study. Cancer Epidemiology, Biomarkers & Prevention. Cancer Epidemiol Biomarkers Prev 25(9):1356-60, 2016. Pubmed PMID: 27365149.

Bhakta N, Liu Q, Yeo F, Baassiri M, Ehrhardt MJ, Srivastava D, Metzger M, Krasin MJ, Ness KK, Hudson MM, Yasui Y, Robison LL. Cumulative burden of cardiovascular morbidity among pediatric Hodgkin lymphoma survivors: a report from the St. Jude Lifetime Cohort Study. Lancet Oncol 17(9):1325-34, 2016. Pubmed PMID: 27470081.

Mulrooney DA, Armstrong GT, Huang S, Ness K, Ehrhardt MJ, Joshi VM, Green DM, Srivastava D, Santucci A, Krasin MT, Robison LL, Hudson MM. Cardiac outcomes in aging survivors of childhood cancer exposed to cardiotoxic therapy. Ann Intern Med 164(2):93-101, 2016. PubMed PMID: 26747086

Ehrhardt MJ, Fulbright JM, Armenian SH. Cardiomyopathy in childhood cancer survivors: lessons from the past and challenges for the future. Curr Oncol Rep 18(4):22, 2016. 

Gibson TM, Ehrhardt MJ, Ness KK. Obesity and metabolic syndrome among adult survivors of childhood leukemia. Curr Treat Options Oncol 17(4):17, 2016.

Ehrhardt MJ, Armenian SH, Fulbright JM. Screening and intervention for treatment-related cardiomyopathy in childhood cancer survivors. Future Oncol 11(114):2031-2034, 2015. PubMed PMID: 26198832

Ehrhardt MJ, Brazauskas R, He W, Rizzo JD, Shaw BE. Survival of patients who develop solid tumors following hematopoietic stem cell transplantation. Bone Marrow Transplantation 14:e1-6, 2015. PubMed PMID: 26367222

Lake JA, Ehrhardt MJ, Suchi M, Chun R, Willoughby RE. Non-toxigenic Corynebacterium diptheriae as an emerging pathogen. Pediatrics 136(1)e242-245, 2015. PubMed PMID: 26055849

Ehrhardt MJ, Mulrooney DA. Metabolic syndrome in adult survivors of childhood cancer: the intersection of oncology, endocrinology, and cardiology. The Lancet Diabetes and Endocrinol 3(7):949-946, 2015. PubMed PMID: 25873570

Ehrhardt MJ, Karst J, Donohoue PA, Maheshwari M, McClain KL, Bingen K, Kelly ME. Recognition and treatment of concurrent active and neurodegenerative Langerhans cell histiocytosis: a case report. J Pediatr Hematol Oncol Jan;37(1):e37-40, 2015. PubMed PMID: 24322503

Ehrhardt MJ, Humphrey SR, Kelly ME, Chiu YE, Galbraith SS. The natural history of skin-limited Langerhans cell histiocytosis: a single-institution experience. Journal of Pediatric Hematology/Oncology Nov;36(8):613-616, 2014. PubMed PMID: 25171449

Brickler MM, Basel DG, Gheorghe G, Margolis DM, Kelly ME, Ehrhardt MJ. Early therapy-related myeloid sarcoma and deletion of 9q22.32 to q31.1: a case report. Pediatr Blood Cancer Sep;61(9):1701-03, 2014. PubMed PMID: 24668947

Last update: March 2017